Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery

Jayant Vaidya, Professor of Surgery and Oncology,

“UK patients with breast cancer perceive even 5-day post-op radiotherapy as being greatly disruptive. They prefer receiving TARGIT-IORT while they are asleep during surgery – it gives them the feeling of stamping out the cancer without conscious awareness.”